<![CDATA[HEADKON的博客]]>

<![CDATA[HEADKON的博客]]>https://blog.youkuaiyun.com/HEADKONzh-cnhttps://blog.youkuaiyun.com/<![CDATA[特立氟胺和西尼莫德、芬戈莫德对比，怎么选更合适？]]>https://blog.youkuaiyun.com/HEADKON/article/details/168656641https://blog.youkuaiyun.com/HEADKON/article/details/168656641HEADKONWed, 21 Oct 2026 16:09:49 +0800<![CDATA[伏索利肽除了软骨发育不全，可以用于低软骨发育症吗？]]>https://blog.youkuaiyun.com/HEADKON/article/details/168653645https://blog.youkuaiyun.com/HEADKON/article/details/168653645HEADKONWed, 21 Oct 2026 14:48:21 +0800<![CDATA[硬纤维瘤γ-分泌酶抑制剂尼洛加司他Nirogacestat用药科普：机制、疗效、剂量与不良反应管理【海得康】]]>https://blog.youkuaiyun.com/HEADKON/article/details/167911553https://blog.youkuaiyun.com/HEADKON/article/details/167911553HEADKONWed, 14 Oct 2026 14:12:52 +0800<![CDATA[米达美替尼（Mirdametinib）用药科普：机制、疗效、剂量与不良反应管理]]>https://blog.youkuaiyun.com/HEADKON/article/details/167911165https://blog.youkuaiyun.com/HEADKON/article/details/167911165HEADKONWed, 14 Oct 2026 14:05:40 +0800<![CDATA[宗艾替尼Zongertinib治疗HER2突变经治患者客观缓解率达71%【海得康】]]>https://blog.youkuaiyun.com/HEADKON/article/details/167907433https://blog.youkuaiyun.com/HEADKON/article/details/167907433HEADKONWed, 14 Oct 2026 13:58:34 +0800<![CDATA[BRCA/HRD 突变卵巢癌患者必读：尼拉帕利维持治疗的优势、适用人群与用药注意]]>https://blog.youkuaiyun.com/HEADKON/article/details/167907124https://blog.youkuaiyun.com/HEADKON/article/details/167907124HEADKONWed, 14 Oct 2026 12:57:49 +0800<![CDATA[达拉索拉西布Daraxonrasib治疗胰腺导管腺癌：生存期近乎翻倍，老挝仿制药已上市]]>https://blog.youkuaiyun.com/HEADKON/article/details/167806836https://blog.youkuaiyun.com/HEADKON/article/details/167806836HEADKONTue, 13 Oct 2026 15:13:20 +0800<![CDATA[贝罗司他防遗传性血管性水肿：每天一粒，能把发作压到多低？]]>https://blog.youkuaiyun.com/HEADKON/article/details/167790506https://blog.youkuaiyun.com/HEADKON/article/details/167790506HEADKONTue, 13 Oct 2026 11:05:32 +0800<![CDATA[宗格替尼治HER2突变肺癌：缓解能撑多久？中位14.1个月的数据说明了什么]]>https://blog.youkuaiyun.com/HEADKON/article/details/167788850https://blog.youkuaiyun.com/HEADKON/article/details/167788850HEADKONTue, 13 Oct 2026 10:46:43 +0800<![CDATA[胆管癌国内外获批靶向药 · 核心临床疗效数据汇总]]>https://blog.youkuaiyun.com/HEADKON/article/details/167689421https://blog.youkuaiyun.com/HEADKON/article/details/167689421HEADKONMon, 12 Oct 2026 13:23:03 +0800<![CDATA[Etcamah临床安全性数据全解析：心律失常风险与全维度不良反应管理规范]]>https://blog.youkuaiyun.com/HEADKON/article/details/167482923https://blog.youkuaiyun.com/HEADKON/article/details/167482923HEADKONSat, 10 Oct 2026 12:55:10 +0800<![CDATA[Omcazio卡博替尼不良反应全解析：从常见轻反应到致命高危信号的规范管理‌]]>https://blog.youkuaiyun.com/HEADKON/article/details/167481319https://blog.youkuaiyun.com/HEADKON/article/details/167481319HEADKONSat, 10 Oct 2026 12:23:10 +0800<![CDATA[Omcazio卡博替尼临床用药规范详解：从起始剂量到换药全流程说明]]>https://blog.youkuaiyun.com/HEADKON/article/details/167478771https://blog.youkuaiyun.com/HEADKON/article/details/167478771HEADKONSat, 10 Oct 2026 11:50:31 +0800<![CDATA[胰腺癌靶向药适应症全景对比：Rasonque达拉西布如何打破受益人群局限]]>https://blog.youkuaiyun.com/HEADKON/article/details/167376800https://blog.youkuaiyun.com/HEADKON/article/details/167376800HEADKONFri, 09 Oct 2026 11:36:28 +0800<![CDATA[从Cabometyx切换到Omcazio：卡博替尼换药全方位指南与注意事项]]>https://blog.youkuaiyun.com/HEADKON/article/details/167368240https://blog.youkuaiyun.com/HEADKON/article/details/167368240HEADKONFri, 09 Oct 2026 10:26:21 +0800<![CDATA[新药获批丨Anzupgo乳膏使用指南——慢性手湿疹患者的新选择]]>https://blog.youkuaiyun.com/HEADKON/article/details/165855798https://blog.youkuaiyun.com/HEADKON/article/details/165855798HEADKONFri, 18 Sep 2026 11:02:14 +0800<![CDATA[玛伐凯泰Mavacamten用药须知——心脏功能监测与药物相互作用]]>https://blog.youkuaiyun.com/HEADKON/article/details/165852937https://blog.youkuaiyun.com/HEADKON/article/details/165852937HEADKONFri, 18 Sep 2026 10:42:39 +0800<![CDATA[普托马尼Pretomanid联合治疗方案——BPaL方案的实施与监测]]>https://blog.youkuaiyun.com/HEADKON/article/details/165851721https://blog.youkuaiyun.com/HEADKON/article/details/165851721HEADKONFri, 18 Sep 2026 10:36:05 +0800<![CDATA[英菲格拉替尼Infigratinib治疗期间高磷血症与视网膜病变管理]]>https://blog.youkuaiyun.com/HEADKON/article/details/165850944https://blog.youkuaiyun.com/HEADKON/article/details/165850944HEADKONFri, 18 Sep 2026 10:31:23 +0800<![CDATA[埃拉菲布拉诺Elafibranor的肝功能监测与不良反应管理]]>https://blog.youkuaiyun.com/HEADKON/article/details/165850468https://blog.youkuaiyun.com/HEADKON/article/details/165850468HEADKONFri, 18 Sep 2026 10:26:40 +0800